Success stories Archive - Page 21 sur 45 - Prestwick Chemical Libraries

success-story

Success Stories


Publications
Screening of a chemical library reveals novel PXR-activating pharmacologic compounds

Toxicology Letters

Ratajewski M, Grzelak I, Wi??niewska K, Ryba K, Gorzkiewicz M, Walczak-Drzewiecka A, Hoffmann M, Dastych J
Toxicology Letters - vol. 232 193-202 (2015)

The pregnane X receptor (PXR) is one of the master regulators of xenobiotic transformation. Interactions between pharmacologic compounds and PXR frequently result in drug-to-drug interactions, drug-induced hepatotoxicity, and the development of drug-resistant phenotypes in cancer cells. Potential PXR-mediated effects on drug metabolism can be predicted using high-throughput methods to detect PXR transactivation. We used the […]

Publications
High-throughput screening for modulators of cellular contractile force.

Integrative biology : quantitative biosciences from nano to macro

Park CY, Zhou EH, Tambe D, Chen B, Lavoie T, Dowell M, Simeonov A, Maloney DJ, Marinkovic A, Tschumperlin DJ, Burger S, Frykenberg M, Butler JP, Stamer WD, Johnson M, Solway J, Fredberg JJ, Krishnan R
Integrative biology : quantitative biosciences from nano to macro - vol. 7 1-16 (2015)

When cellular contractile forces are central to pathophysiology, these forces comprise a logical target of therapy. Nevertheless, existing high-throughput screens are limited to upstream signalling intermediates with poorly defined relationships to such a physiological endpoint. Using cellular force as the target, here we report a new screening technology and demonstrate its applications using human airway […]

Publications
Screening for Small-Molecule Modulators of Long Noncoding RNA-Protein Interactions Using AlphaScreen.

Journal of biomolecular screening

Pedram Fatemi R, Salah-Uddin S, Modarresi F, Khoury N, Wahlestedt C, Faghihi MA
Journal of biomolecular screening - vol. 20 1132-41 (2015)

Long non-protein coding RNAs (lncRNAs) are an important class of molecules that help orchestrate key cellular events. Although their functional roles in cells are not well understood, thousands of lncRNAs and a number of possible mechanisms by which they act have been reported. LncRNAs can exert their regulatory function in cells by interacting with epigenetic […]

Publications
A whole-cell assay for specific inhibitors of translation initiation in bacteria.

Journal of biomolecular screening

Raneri M, Sciandrone B, Briani F
Journal of biomolecular screening - vol. 20 627-33 (2015)

The bacterial translational apparatus is an ideal target for the search of new antibiotics. In fact, it performs an essential process carried out by a large number of potential subtargets for antibiotic action. Moreover, it is sufficiently different in several molecular details from the apparatus of Eukarya and Archaea to generally ensure specificity for the […]

Publications
Inhibitors of tissue transglutaminase

Trends in Pharmacological Sciences

Keillor JW, Apperley KYP, Akbar A
Trends in Pharmacological Sciences - vol. 36 32-40 (2015)

Tissue transglutaminase (TG2) catalyzes the cross-linking of proteins by the formation of isopeptide bonds between glutamine (Gln) and lysine (Lys) side chains. Although TG2 is essential for the stabilization of the extracellular matrix, its unregulated activity has been implicated in celiac disease, fibrosis, and cancer metastasis, among other disorders. Given the importance and range of […]

Publications
Fluorescence polarization screening assays for small molecule allosteric modulators of ABL kinase function

PLoS ONE

Grover P, Shi H, Baumgartner M, Camacho CJ, Smithgall TE
PLoS ONE - vol. 10 1-26 (2015)

The ABL protein-tyrosine kinase regulates intracellular signaling pathways controlling diverse cellular processes and contributes to several forms of cancer. The kinase activity of ABL is repressed by intramolecular interactions involving its regulatory Ncap, SH3 and SH2 domains. Small molecules that allosterically regulate ABL kinase activity through its non-catalytic domains may represent selective probes of ABL […]

Publications
Applications of flow cytometry for measurement of autophagy

Methods

Demishtein A, Porat Z, Elazar Z, Shvets E
Methods - vol. 75 87-95 (2015)

Autophagy is a dynamic catabolic process that plays a major role in sequestering and recycling cellular components in multiple physiological and pathophysiological conditions. Despite recent progress in our understanding of the autophagic process there is still a shortage of robust methods for monitoring autophagy in live cells. Flow cytometry, a reliable and unbiased method for […]

Publications
G protein-coupled receptor 35: An emerging target in inflammatory and cardiovascular disease

Frontiers in Pharmacology

Divorty N, Mackenzie AE, Nicklin SA, Milligan G
Frontiers in Pharmacology - vol. 6 1-13 (2015)

G protein-coupled receptor 35 (GPR35) is an orphan receptor, discovered in 1998, that has garnered interest as a potential therapeutic target through its association with a range of diseases. However, a lack of pharmacological tools and the absence of convincingly defined endogenous ligands have hampered the understanding of function necessary to exploit it therapeutically. Although […]

Publications
Preclinical combination therapy of the investigational drug NAMI-A+ with doxorubicin for mammary cancer

Investigational New Drugs

Bergamo A, Riedel T, Dyson PJ, Sava G
Investigational New Drugs - vol. 33 53-63 (2015)

AIM OF THE STUDY: The tumor metastases targeting ruthenium complex NAMI-A synergistically improves the activity of gemcitabine in combination therapies. High-throughput screening was used to identify other potential drug combinations from a library of FDA approved drugs. Doxorubicin was identified as a hit compound and was therefore evaluated in combination with NAMI-A in vitro and […]

Publications
Identification of new MRP4 inhibitors from a library of FDA approved drugs using a high-throughput bioluminescence screen

Biochemical Pharmacology

Cheung L, Yu DMT, Neiron Z, Failes TW, Arndt GM, Fletcher JI
Biochemical Pharmacology - vol. 93 380-388 (2015)

Multidrug resistance protein 4 (MRP4) effluxes a wide variety of drugs and endogenous signaling molecules from cells and has been proposed as an attractive therapeutic target in several solid tumors, including neuroblastoma and colorectal cancer. MRP4 also regulates the pharmacokinetics of its drug substrates and its absence can increase their tissue penetration. We observed that […]